NLSP (nlspharma.com) Net Profit

Official company branding of NLS Pharmaceutics (NLSP)

NLS Pharmaceutics AG (NLSP) minimizes scientific risks by developing treatments for cognitive impairment and sleep disorders. The company's bottom line on the GURU.Markets chart confirms the effectiveness of its patent-protected unique drug delivery method. High market demand for narcolepsy therapy supports growth, while -0.01 captures the current state of the company's profit parameter.

NLSP (NLS Pharmaceutics AG) Company Net Income history from 07/04/2022 to 10/31/2025

Comprehensive metric breakdowns and analytics for nlspharma.com (NLSP)

- price and consensus price forecast:
Stock Quotes NLS Pharmaceutics|NLSP - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization NLS Pharmaceutics|NLSP - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share NLS Pharmaceutics|NLSP - Company Book Value|Capitalization to Book Value Ratio nlspharma.com|NLSP - Company Total Assets
- debt and solvency information:
Debt to Capital NLS Pharmaceutics AG|NLSP - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital NLS Pharmaceutics|NLSP - Company Debts|Debt to Net Assets Ratio NLS Pharmaceutics|NLSP - Company Long-Term Debt|Short-Term Debt NLS Pharmaceutics|Quick Liquidity nlspharma.com
- net income and valuation multiples indicators:
NLSP - Company Net Income
Basic company analysis:NLS Pharma (NLSP)
Signature product of nlspharma.com

The net profit growth of NLS Pharmaceutics AG (NLSP) reflects the company's ability to monetize its leadership in the safe narcolepsy treatment segment, converting innovation into actual revenue. This indicator captures the market consensus regarding the bottom line after all expenses, allowing investors to assess the stability of cash flows and the efficiency of the business's operational cost coverage.

Main competitors

Net Income Jazz Pharmaceuticals Corp|CYTK (Cytokinetics) - Net Profit|Net Profit ptcbio.com|Net Income SRRK (Scholar Rock Holding Corporation)|CNTA (Centessa Pharmaceuticals plc) - Final Profit|Company Net Income Dyne Pharma DYN|EWTX: Company Profit|Rapport Therapeutics, Inc. - Net Profit|Company Net Income alumis.com|ZVRA (Zevra Therapeutics, Inc.) - Net Income|Contineum Therapeutics Inc (CTNM) - Net Profit|Company Net Income Larimar Pharma|CAPR: Final Profit|Company Net Income Entrada Therapeutics (TRDA)|PTHS - Company Net Income|Company Net Income MediciNova MNOV|Serina Therapeutics Inc - Company Net Income|BTAI - Company Net Income|Company Net Income ProMIS Neurosciences|APUS: Net Profit|Annual Net Income AEON Biopharma, Inc. AEON|Net Income BNOX|Company Net Income FSD Pharma, Inc. HUGE|Company Net Income Reata (RETA)